Minerva Surgical, Inc. Stock price

Equities

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 11:34:58 2023-12-01 am EST Intraday chart for Minerva Surgical, Inc. 5-day change 1st Jan Change
1.957 USD +4.65% +13.12% -56.20%
Sales 2023 * 51.81 M Sales 2024 * 59.61 M Capitalization 16.60 M
Net income 2023 * -32.00 M Net income 2024 * -28.00 M EV / Sales 2023 *
0,32x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 *
0,28x
P/E ratio 2023 *
-0,46x
P/E ratio 2024 *
-0,65x
Employees 174
Yield 2023 *
-
Yield 2024 *
-
Free-Float 30.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.65%
1 week+13.12%
Current month+4.65%
1 month-40.79%
3 months-52.85%
6 months-51.08%
Current year-56.20%
More quotes
1 week
1.56
Extreme 1.56
1.97
1 month
1.55
Extreme 1.55
3.23
Current year
1.55
Extreme 1.55
14.00
1 year
1.55
Extreme 1.55
14.00
3 years
1.55
Extreme 1.55
207.40
5 years
1.55
Extreme 1.55
207.40
10 years
1.55
Extreme 1.55
207.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - Jan. 01
Director of Finance/CFO 65 2020
Chief Tech/Sci/R&D Officer 57 2010
Members of the board TitleAgeSince
Chairman 55 Feb. 08
Director/Board Member 46 2011
Director/Board Member 50 2022
More insiders
Date Price Change Volume
23-12-01 1.957 +4.65% 15 234
23-11-30 1.870 +19.87% 136,898
23-11-29 1.560 -4.88% 16,379
23-11-28 1.640 -1.20% 15,820
23-11-27 1.660 -4.05% 8,171

Delayed Quote Nasdaq, December 01, 2023 at 11:34 am EST

More quotes
Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. It has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. It offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.870USD
Average target price
3.000USD
Spread / Average Target
+60.43%
Consensus
  1. Stock
  2. Equities
  3. Stock Minerva Surgical, Inc. - Nasdaq
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer